ST5 Positively Regulates Osteoclastogenesis Via Src/Syk/Calcium Signaling Pathways

Total Page:16

File Type:pdf, Size:1020Kb

ST5 Positively Regulates Osteoclastogenesis Via Src/Syk/Calcium Signaling Pathways Molecules and Cells ST5 Positively Regulates Osteoclastogenesis via Src/Syk/Calcium Signaling Pathways Min Kyung Kim, Bongjun Kim, Jun-Oh Kwon, Min-Kyoung Song, Suhan Jung, Zang Hee Lee, and Hong- Hee Kim* Department of Cell and Developmental Biology, BK21 Program and Dental Research Institute (DRI), School of Dentistry, Seoul National University, Seoul 03080, Korea *Correspondence: [email protected] https://doi.org/10.14348/molcells.2019.0189 www.molcells.org For physiological or pathological understanding of bone INTRODUCTION disease caused by abnormal behavior of osteoclasts (OCs), functional studies of molecules that regulate the generation Bone is a dynamic organ that is constantly being disrupted and action of OCs are required. In a microarray approach, and restructured for maintenance of homeostasis (Zaidi, we found the suppression of tumorigenicity 5 (ST5) gene 2007). The process of bone resorption is controlled by ac- is upregulated by receptor activator of nuclear factor-κB tion of osteoclasts (OCs), which are multinucleated cells ligand (RANKL), the OC differentiation factor. Although the (MNCs) generated from a monocyte/macrophage lineage of roles of ST5 in cancer and β-cells have been reported, the hemopoietic cells (Boyle et al., 2003; Rho et al., 2004). The function of ST5 in bone cells has not yet been investigated. action of excessive OCs induces an imbalance in homeostasis, Knockdown of ST5 by siRNA reduced OC differentiation triggering pathological bone diseases, such as osteoporosis from primary precursors. Moreover, ST5 downregulation (Zaidi, 2007). decreased expression of NFATc1, a key transcription factor Osteoclastogenesis is a multi-step process including com- for osteoclastogenesis. In contrast, overexpression of ST5 mitment of OC precursor cells to mononucleated preosteo- resulted in the opposite phenotype of ST5 knockdown. In clasts (pOCs), fusion for formation of multinucleated OCs, immunocytochemistry experiments, the ST5 protein is co- and maturation of OCs for bone resorption activity. The localized with Src in RANKL-committed cells. In addition, process requires the action of two essential factors, mac- ST5 enhanced activation of Src and Syk, a Src substrate, in rophage-colony-stimulating factor (M-CSF) and receptor response to RANKL. ST5 reduction caused a decrease in activator of nuclear factor-κB ligand (RANKL) (Boyle et al., RANKL-evoked calcium oscillation and inhibited translocation 2003; Rho et al., 2004). The binding of RANKL to its receptor of NFATc1 into the nucleus. Taken together, these findings (RANK) initiates recruitment of tumor necrosis factor (TNF) re- provide the first evidence of ST5 involvement in positive ceptor-associated factor 6 (TRAF6) (Darnay et al., 1999) and regulation of osteoclastogenesis via Src/Syk/calcium signaling. activates downstream signaling molecules including MAPKs (ERK, JNK, and p38), NFκB, and AP-1 complex (a protein Keywords: calcium, NFATc1, osteoclasts, RANKL, Src, complex of c-Jun and c-Fos) (Park et al., 2017; Takayanagi, suppression of tumorigenicity 5, Syk 2005). Finally, these signaling pathways induce expression of the nuclear factor of activated T cells c1 (NFATc1), which is a key transcription factor for osteoclastogenesis. NFATc1 Received 23 August, 2019; revised 24 September, 2019; accepted 25 September, 2019; published online 11 November, 2019 eISSN: 0219-1032 ©The Korean Society for Molecular and Cellular Biology. All rights reserved. cc This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/. 810 Mol. Cells 2019; 42(11): 810-819 The Role of ST5 in Osteoclastogenesis Min Kyung Kim et al. induces OC-specific genes, including tartrate-resistant acid Bone marrow-derived macrophage (BMM) isolation and phosphatase (TRAP) and cathepsin K (Kim and Kim, 2014). OC differentiation Calcium signaling is known to play a role in NFATc1 activation Bone marrow from the tibiae and femurs of 5-week-old by promoting its nuclear translocation. When RANKL triggers ICR mice was flushed with α-MEM (Welgene, Korea). After a signal for induction of osteoclastogenesis, calcium signaling removing erythrocytes with red blood cell lysis buffer (Invit- is stimulated via activation of PLCγ, which leads to generation rogen), cells were cultured in α-MEM containing 10% fetal of inositol 1,4,5-trisphosphate (IP3) and its binding to IP3 bovine serum overnight in culture dishes. Non-adherent bone receptors on the endoplasmic reticulum (ER) (Kim and Kim, marrow cells were collected and cultured in the presence 2014; Koga et al., 2004). In addition, Src- and Src substrate of M-CSF (30 ng/ml) for three days in 100 mm-Petri dishes. Syk-dependent signaling is involved in activation of PLCγ by Adherent cells (BMMs) were considered to be OC precursors RANKL (Tomomura et al., 2012; Yamasaki et al., 2014). and harvested. BMMs were seeded at 3.5 × 104 per well Suppression of tumorigenicity 5 (ST5) can exist in three in 48-well plates or 3.5 × 105 per well in 6-well plates with isoforms including p70 (isoform3), p82 (isoform2), and p126 M-CSF (30 ng/ml) and cultured with M-CSF (30 ng/ml) and (isoform1) encoded by alternatively spliced transcripts (2.8 RANKL (150 ng/ml) for 4 or 5 days to induce OC formation. kb, 3.1 kb, 4.6 kb mRNA, respectively) (Lichy et al., 1992). Cells were fixed in 3.7% formaldehyde and permeabilized The shortest form ST5 p70 is related with low tumorigenicity using 0.1% Triton X-100. TRAP staining was performed in and is the reason for the naming of the ST5 gene (Lichy et al., the dark for 10 minutes according to the manufacturer’s pro- 1992), whereas the longest ST5 p126 activates ERK signaling tocol. Multinucleated TRAP-positive cells were captured and in response to EGF on COS-7 cells (Majidi et al., 1998). Phys- counted under an Olympus BX51 microscope (Japan). iologically, the N-terminal domain of p126 binds the Src-ho- mology 3 (SH3) domain of c-Abl, leading to activation of the Microarray MAPK/ERK2 kinase. Moreover, the N-terminal domain of ST5 BMMs were cultured in α-MEM with M-CSF (30 ng/ml) and p126 also binds the SH3 domain of Src (Majidi et al., 1998). RANKL (150 ng/ml). Total RNA was prepared from untreated The C-terminal region of ST5 p126 binds and catalyzes the cells (day 0), and cells treated with RANKL (day 3) and was exchange of GDP to GTP of the Rab 13 protein, which pro- then hybridized with Mouse WG-6 v2.0 BeadChips (Illumina, motes metastatic behavior (Ioannou et al., 2015). In addition USA). Microarray data were analyzed with the Genome Stu- to its function in cancer, the downregulation of ST5 has been dio Gene Expression Module (Gx) v3.2 (Illumina). correlated with mutation of hepatocyte nuclear factor-4α (HNF-4α), a key regulator of β-cell proliferation (Ou et al., ST5 gene knockdown by siRNA 2018). However, to our knowledge, there is no report of ST5 BMMs were transfected with 25 nM ST5 siRNA (sc-153863; expression or function in the skeletal system. Santa Cruz Biotechnology). In brief, siRNA and transfection In this report, we found that ST5 is induced by RANKL reagent HiPerFect (Qiagen, The Netherlands) were mixed during OC differentiation. In loss- and gain-of-function stud- with serum-free α-MEM medium. After the mixtures were ies, we revealed that ST5 promotes OC differentiation by up- incubated for 20 min at room temperature, they were added regulating NFATc1 via activation of Src/Syk/calcium signaling. to the cells. MATERIALS AND METHODS Bone resorption assay To determine osteoclast lytic activity, BMMs (1 × 104) were Reagents seeded on dentine discs (Osteosite Dentine Discs; Immu- Recombinant human M-CSF and RANKL were purchased nodiagnostic Systems, UK) in 96-well plate and transfected from PeproTech (USA). Anti-NFATc1 was acquired from BD with ST5 siRNA or control siRNA. Cells were cultured with Biosciences (USA). Anti-c-Fos anti-α-tubulin were purchased M-CSF (30 ng/ml) and RANKL (150 ng/ml) for 7 to 9 days. from Santa Cruz Biotechnology (USA). Polyclonal antibodies The plates were rinsed with distilled water to remove cells against ERK, JNK, p38, IκB, phospho-ERK, phospho-JNK, for 15 min, and the dentine discs were carefully wiped with phospho-p38, phospho-IκB, phospho-Src family, and phos- a cotton swab. The discs were scanned with a Carl Zeiss LSM pho-Syk were purchased from Cell Signaling Technology 5-PASCAL laser-scanning microscope (Carl Zeiss Microimag- (USA). A monoclonal antibody against β-actin was obtained ing, Germany). The areas and depths of 50 resorption pits in from Sigma Aldrich (USA). The NE-PER Nuclear and Cytoplas- each sample were determined with image analysis software mic Extraction Reagents Kit was obtained from Invitrogen (LSM 5 Image Browser; Carl Zeiss Microimaging). The assay (Carlsbad, CA, USA). The TRAP staining kit was purchased was performed in triplicate wells per group. from Sigma Aldrich. Reverse transcription-polymerase chain reaction (RT-PCR) Animals and real-time PCR The ICR mice used for preparation of OC precursor cells were After extraction of total RNA using Trizol (Invitrogen), 3 μg of purchased from OrientBio (Korea). All animal experiments RNA was reverse transcribed into cDNA using Superscript II were performed with approval of the Institutional Animal (Invitrogen) according to the manufacturer's instructions. The Care and Use Committee at Seoul National University (SNU- PCR reaction was performed as follows: denaturation at 95oC 160105-3-5) and conducted according to the Guidelines for for 15 s and annealing at 60oC or 57oC for 30 s. PCR prod- Animal Experimentation. ucts were loaded onto 1.5% agarose gels. The Hprt gene Mol. Cells 2019; 42(11): 810-819 811 The Role of ST5 in Osteoclastogenesis Min Kyung Kim et al.
Recommended publications
  • ENSG Gene Encodes Effector TCR Pathway Costimulation Inhibitory/Exhaustion Synapse/Adhesion Chemokines/Receptors
    ENSG Gene Encodes Effector TCR pathway Costimulation Inhibitory/exhaustion Synapse/adhesion Chemokines/receptors ENSG00000111537 IFNG IFNg x ENSG00000109471 IL2 IL-2 x ENSG00000232810 TNF TNFa x ENSG00000271503 CCL5 CCL5 x x ENSG00000139187 KLRG1 Klrg1 x ENSG00000117560 FASLG Fas ligand x ENSG00000121858 TNFSF10 TRAIL x ENSG00000134545 KLRC1 Klrc1 / NKG2A x ENSG00000213809 KLRK1 Klrk1 / NKG2D x ENSG00000188389 PDCD1 PD-1 x x ENSG00000117281 CD160 CD160 x x ENSG00000134460 IL2RA IL-2 receptor x subunit alpha ENSG00000110324 IL10RA IL-10 receptor x subunit alpha ENSG00000115604 IL18R1 IL-18 receptor 1 x ENSG00000115607 IL18RAP IL-18 receptor x accessory protein ENSG00000081985 IL12RB2 IL-12 receptor x beta 2 ENSG00000186810 CXCR3 CXCR3 x x ENSG00000005844 ITGAL CD11a x ENSG00000160255 ITGB2 CD18; Integrin x x beta-2 ENSG00000156886 ITGAD CD11d x ENSG00000140678 ITGAX; CD11c x x Integrin alpha-X ENSG00000115232 ITGA4 CD49d; Integrin x x alpha-4 ENSG00000169896 ITGAM CD11b; Integrin x x alpha-M ENSG00000138378 STAT4 Stat4 x ENSG00000115415 STAT1 Stat1 x ENSG00000170581 STAT2 Stat2 x ENSG00000126561 STAT5a Stat5a x ENSG00000162434 JAK1 Jak1 x ENSG00000100453 GZMB Granzyme B x ENSG00000145649 GZMA Granzyme A x ENSG00000180644 PRF1 Perforin 1 x ENSG00000115523 GNLY Granulysin x ENSG00000100450 GZMH Granzyme H x ENSG00000113088 GZMK Granzyme K x ENSG00000057657 PRDM1 Blimp-1 x ENSG00000073861 TBX21 T-bet x ENSG00000115738 ID2 ID2 x ENSG00000176083 ZNF683 Hobit x ENSG00000137265 IRF4 Interferon x regulatory factor 4 ENSG00000140968 IRF8 Interferon
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • 3034.Full.Pdf
    Characterization of the CD200 Receptor Family in Mice and Humans and Their Interactions with CD200 This information is current as Gavin J. Wright, Holly Cherwinski, Mildred Foster-Cuevas, of September 28, 2021. Gary Brooke, Michael J. Puklavec, Mike Bigler, Yaoli Song, Maria Jenmalm, Dan Gorman, Terri McClanahan, Man-Ru Liu, Marion H. Brown, Jonathon D. Sedgwick, Joseph H. Phillips and A. Neil Barclay J Immunol 2003; 171:3034-3046; ; Downloaded from doi: 10.4049/jimmunol.171.6.3034 http://www.jimmunol.org/content/171/6/3034 References This article cites 39 articles, 20 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/171/6/3034.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 28, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2003 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Characterization of the CD200 Receptor Family in Mice and Humans and Their Interactions with CD2001 Gavin J.
    [Show full text]
  • Meta-Analysis of Nasopharyngeal Carcinoma
    BMC Genomics BioMed Central Research article Open Access Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation Xia Chen†1,2, Shuang Liang†1, WenLing Zheng1,3, ZhiJun Liao1, Tao Shang1 and WenLi Ma*1 Address: 1Institute of Genetic Engineering, Southern Medical University, Guangzhou, PR China, 2Xiangya Pingkuang associated hospital, Pingxiang, Jiangxi, PR China and 3Southern Genomics Research Center, Guangzhou, Guangdong, PR China Email: Xia Chen - [email protected]; Shuang Liang - [email protected]; WenLing Zheng - [email protected]; ZhiJun Liao - [email protected]; Tao Shang - [email protected]; WenLi Ma* - [email protected] * Corresponding author †Equal contributors Published: 7 July 2008 Received: 16 February 2008 Accepted: 7 July 2008 BMC Genomics 2008, 9:322 doi:10.1186/1471-2164-9-322 This article is available from: http://www.biomedcentral.com/1471-2164/9/322 © 2008 Chen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Epstein-Barr virus (EBV) presumably plays an important role in the pathogenesis of nasopharyngeal carcinoma (NPC), but the molecular mechanism of EBV-dependent neoplastic transformation is not well understood. The combination of bioinformatics with evidences from biological experiments paved a new way to gain more insights into the molecular mechanism of cancer. Results: We profiled gene expression using a meta-analysis approach. Two sets of meta-genes were obtained. Meta-A genes were identified by finding those commonly activated/deactivated upon EBV infection/reactivation.
    [Show full text]
  • CD200 and Its Receptor, CD200R, Modulate Bone Mass Via the Differentiation of Osteoclasts
    CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts Weiguo Cui*†, Esteban Cuartas*, Juan Ke*‡, Qing Zhang*, Halldor B. Einarsson*, Jonathon D. Sedgwick§¶, Jun Liʈ, and Agne` s Vignery*,** *Department of Orthopedics and Rehabilitation, Yale School of Medicine, 310 Cedar Street, New Haven, CT 06510; §Schering–Plough Biopharma (DNAX), Palo Alto, CA 94304; and ʈDepartment of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 Edited by Richard A. Flavell, Yale University School of Medicine, New Haven, CT, and approved July 25, 2007 (received for review April 11, 2007) Fusion of macrophages is an essential step in the differentiation of plays a role in the recognition of self and in the fusion of macro- osteoclasts, which play a central role in the development and remod- phages (10). To gain further insight into the mechanism of mac- eling of bone. Osteoclasts are important mediators of bone loss, rophage fusion, we subjected fusing alveolar macrophages from rats which leads, for example, to osteoporosis. Macrophage fusion recep- to genome-wide oligonucleotide microarray analysis, and we dis- tor/signal regulatory protein ␣ (MFR/SIRP␣) and its ligand CD47, covered the expression of CD200 de novo at the onset of fusion. which are members of the Ig superfamily (IgSF), have been implicated CD200 also belongs to the IgSF and has a short cytoplasmic tail. in the fusion of macrophages. We show that CD200, which is not It is expressed on various types of mouse and human cells (see ref. expressed in cells that belong to the myeloid lineage, is strongly 11 for a review) and on mouse osteoblasts (12), but not on expressed in macrophages at the onset of fusion.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Concerted Genomic and Epigenomic Changes Accompany Stabilization of Arabidopsis Allopolyploids
    ARTICLES https://doi.org/10.1038/s41559-021-01523-y Concerted genomic and epigenomic changes accompany stabilization of Arabidopsis allopolyploids Xinyu Jiang 1, Qingxin Song 1,2, Wenxue Ye 1 and Z. Jeffrey Chen 2 ✉ During evolution successful allopolyploids must overcome ‘genome shock’ between hybridizing species but the underlying pro- cess remains elusive. Here, we report concerted genomic and epigenomic changes in resynthesized and natural Arabidopsis suecica (TTAA) allotetraploids derived from Arabidopsis thaliana (TT) and Arabidopsis arenosa (AA). A. suecica shows con- served gene synteny and content with more gene family gain and loss in the A and T subgenomes than respective progenitors, although A. arenosa-derived subgenome has more structural variation and transposon distributions than A. thaliana-derived subgenome. These balanced genomic variations are accompanied by pervasive convergent and concerted changes in DNA methylation and gene expression among allotetraploids. The A subgenome is hypomethylated rapidly from F1 to resynthesized allotetraploids and convergently to the T-subgenome level in natural A. suecica, despite many other methylated loci being inher- ited from F1 to all allotetraploids. These changes in DNA methylation, including small RNAs, in allotetraploids may affect gene expression and phenotypic variation, including flowering, silencing of self-incompatibility and upregulation of meiosis- and mitosis-related genes. In conclusion, concerted genomic and epigenomic changes may improve stability and adaptation during polyploid evolution. olyploidy or whole-genome duplication (WGD) is a perva- species, including Aly24, Aha25 and Aka26, having been sequenced, sive feature of genome evolution in animals and flowering A. arenosa and A. suecica genomes are unavailable, except for a draft Pplants1–6.
    [Show full text]
  • A New Insight Into Viral Proteins As Immunomodulatory Therapeutic Agents
    Iranian Journal of Basic Medical Sciences ijbms.mums.ac.ir A new insight into viral proteins as Immunomodulatory therapeutic agents. KSHV vOX2 a homolog of human CD200 as a potent anti-inflammatory protein Maryam Mousavinezhad-Moghaddam 1, Abbas Ali Amin 2, Houshang Rafatpanah 3, Seyed Abdol Rahim Rezaee 4 * 1 Department of Physiology, Biology Division, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran 2 Department of Immunology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran 3 Immunology Research Centre, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran 4 Inflammation and Inflammatory Diseases Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran A R T I C L E I N F O A B S T R A C T Article type: Review article The physiologic function of the immune system is defence against infectious microbes and tumour Article history: cells, Therefore, need to have precise modulatory mechanisms to maintain the body homeostasis. The Received: Aug 12, 2014 mammalian cellular CD200 (OX2)/CD200R interaction is one of such modulatory mechanisms in which Accepted: Nov 13, 2014 myeloid and lymphoid cells are regulated. CD200 and CD200R molecules are membrane proteins that Keywords: their immunomodulatory effects are able to suppress inflammatory responses, particularly in the CD200 privilege sites such as CNS and eyes. Kaposi’s sarcoma-associated herpesvirus (KSHV), encodes a wide Immune modulation variety of immunoregulatory proteins which play central roles in modulating inflammatory and anti- KSHV inflammatory responses in favour of virus dissemination. One such protein is a homologue of the RGD human CD200, encoded by open reading frame (ORF) K14 and therefore called vOX2/vCD200.
    [Show full text]
  • Review Article the Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis
    Hindawi Publishing Corporation Stem Cells International Volume 2016, Article ID 1908365, 13 pages http://dx.doi.org/10.1155/2016/1908365 Review Article The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis Wessam E. Sharaf-Eldin,1,2 Nourhan Abu-Shahba,2,3 Marwa Mahmoud,1,2,3 and Nagwa El-Badri1 1 Center of Excellence of Stem Cells and Regenerative Medicine, Zewail City of Science and Technology, Sheikh Zayed District, 6thofOctoberCity,Giza12566,Egypt 2Medical Molecular Genetics Department, Human Genetics and Genome Research Division, National Research Centre, Cairo 12411, Egypt 3Stem Cells Research Group, Centre of Excellence for Advanced Sciences, National Research Centre, Cairo 12411, Egypt Correspondence should be addressed to Nagwa El-Badri; [email protected] Received 12 July 2015; Accepted 21 September 2015 AcademicEditor:JoelC.Glover Copyright © 2016 Wessam E. Sharaf-Eldin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The effect of mesenchymal stem cells (MSCs) on bone formation has been extensively demonstrated through several in vitro and in vivo studies. However, few studies addressed the effect of MSCs on osteoclastogenesis and bone resorption. Under physiological conditions, MSCs support osteoclastogenesis through producing the main osteoclastogenic cytokines, RANKL and M-CSF. However, during inflammation, MSCs suppress osteoclast formation and activity, partly via secretion of the key anti- osteoclastogenic factor, osteoprotegerin (OPG). In vitro, co-culture of MSCs with osteoclasts in the presence of high concentrations of osteoclast-inducing factors might reflect the in vivo inflammatory pathology and prompt MSCs to exert an osteoclastogenic suppressive effect.
    [Show full text]
  • Molecular Analyses of Malignant Pleural Mesothelioma
    Molecular Analyses of Malignant Pleural Mesothelioma Shir Kiong Lo National Heart and Lung Institute Imperial College Dovehouse Street London SW3 6LY A thesis submitted for MD (Res) Faculty of Medicine, Imperial College London 2016 1 Abstract Malignant pleural mesothelioma (MPM) is an aggressive cancer that is strongly associated with asbestos exposure. Majority of patients with MPM present with advanced disease and the treatment paradigm mainly involves palliative chemotherapy and best supportive care. The current chemotherapy options are limited and ineffective hence there is an urgent need to improve patient outcomes. This requires better understanding of the genetic alterations driving MPM to improve diagnostic, prognostic and therapeutic strategies. This research aims to gain further insights in the pathogenesis of MPM by exploring the tumour transcriptional and mutational profiles. We compared gene expression profiles of 25 MPM tumours and 5 non-malignant pleura. This revealed differentially expressed genes involved in cell migration, invasion, cell cycle and the immune system that contribute to the malignant phenotype of MPM. We then constructed MPM-associated co-expression networks using weighted gene correlation network analysis to identify clusters of highly correlated genes. These identified three distinct molecular subtypes of MPM associated with genes involved in WNT and TGF-ß signalling pathways. Our results also revealed genes involved in cell cycle control especially the mitotic phase correlated significantly with poor prognosis. Through exome analysis of seven paired tumour/blood and 29 tumour samples, we identified frequent mutations in BAP1 and NF2. Additionally, the mutational profile of MPM is enriched with genes encoding FAK, MAPK and WNT signalling pathways.
    [Show full text]
  • CD200 in Hematological Malignancies: Just a Diagnostic Tool Or More?
    Editorial Page 1 of 4 CD200 in hematological malignancies: just a diagnostic tool or more? Daniela Damiani, Mario Tiribelli Division of Hematology and Stem Cell Transplantation, Department of Medical Area, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy Correspondence to: Prof. Daniela Damiani. Division of Hematology and Stem Cell Transplantation Department of Medical Area, Azienda Sanitaria Universitaria Integrata di Udine, 33100 Udine, Italy. Email: [email protected]. Provenance: This is a Guest Editorial commissioned by the Section Editor Baohong Yue (Hematology lab in Department of Clinical Laboratory Medicine, The First Affiliated Hospital, College of Medicine, Zhengzhou University, Zhengzhou, China). Comment on: Sandes AF, de Lourdes Chauffaille M, Oliveira CR, et al. CD200 has an important role in the differential diagnosis of mature B cell neoplasms by multiparameter flow cytometry. Cytometry B Clin Cytom 2014;86:98-105. Received: 28 July 2017; Accepted: 08 August 2017; Published: 15 September 2017. doi: 10.21037/jlpm.2017.08.08 View this article at: http://dx.doi.org/10.21037/jlpm.2017.08.08 Over the past two decades, the increased number of monoclonal Cytometry, Sandes and colleagues tested the diagnostic antibodies and the constantly expanding availability of utility of CD200 in differential diagnosis of 159 patients fluorescence probes significantly improved the efficiency with mature B lymphoproliferative diseases (3). They and the accuracy of flow cytometric analysis, providing not only added CD200 to a conventional MFC panel, relevant information for the diagnosis, classification and evaluating its dichotomous expression, but also compared follow up of various hematological malignancies. As a the fluorescence intensity in the tested cases, with the aim to diagnostic tool, together with morphology and molecular create a reference pool of CD200 expression intensity that genetics, flow cytometry has become a gold standard in may further discriminate within the CD200-positive group.
    [Show full text]
  • On the Role of Chromosomal Rearrangements in Evolution
    On the role of chromosomal rearrangements in evolution: Reconstruction of genome reshuffling in rodents and analysis of Robertsonian fusions in a house mouse chromosomal polymorphism zone by Laia Capilla Pérez A thesis submitted for the degree of Doctor of Philosophy in Animal Biology Supervisors: Dra. Aurora Ruiz-Herrera Moreno and Dr. Jacint Ventura Queija Institut de Biotecnologia i Biomedicina (IBB) Departament de Biologia Cel·lular, Fisiologia i Immunologia Departament de Biologia Animal, Biologia Vegetal i Ecologia Universitat Autònoma de Barcelona Supervisor Supervisor PhD candidate Aurora Ruiz-Herrera Moreno Jacint Ventura Queija Laia Capilla Pérez Bellaterra, 2015 A la mare Al pare Al mano “Visto a la luz de la evolución, la biología es, quizás, la ciencia más satisfactoria e inspiradora. Sin esa luz, se convierte en un montón de hechos varios, algunos de ellos interesantes o curiosos, pero sin formar ninguna visión conjunta.” Theodosius Dobzhansky “La evolución es tan creativa. Por eso tenemos jirafas.” Kurt Vonnegut This thesis was supported by grants from: • Ministerio de Economía y Competitividad (CGL2010-15243 and CGL2010- 20170). • Generalitat de Catalunya, GRQ 1057. • Ministerio de Economía y Competitividad. Beca de Formación de Personal Investigador (FPI) (BES-2011-047722). • Ministerio de Economía y Competitividad. Beca para la realización de estancias breves (EEBB-2011-07350). Covers designed by cintamontserrat.blogspot.com INDEX Abstract 15-17 Acronyms 19-20 1. GENERAL INTRODUCTION 21-60 1.1 Chromosomal rearrangements
    [Show full text]